Marshall Wace LLP trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 29.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 402,181 shares of the real estate investment trust's stock after selling 167,491 shares during the quarter. Marshall Wace LLP owned 0.06% of Healthpeak Properties worth $8,152,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently bought and sold shares of the stock. Zacks Investment Management increased its position in shares of Healthpeak Properties by 6.4% during the fourth quarter. Zacks Investment Management now owns 1,427,638 shares of the real estate investment trust's stock worth $28,938,000 after acquiring an additional 86,501 shares in the last quarter. NewEdge Advisors LLC boosted its stake in Healthpeak Properties by 10.5% in the 4th quarter. NewEdge Advisors LLC now owns 14,409 shares of the real estate investment trust's stock worth $292,000 after purchasing an additional 1,371 shares during the period. Insigneo Advisory Services LLC increased its holdings in Healthpeak Properties by 9.5% during the 4th quarter. Insigneo Advisory Services LLC now owns 15,455 shares of the real estate investment trust's stock worth $313,000 after purchasing an additional 1,339 shares in the last quarter. United Capital Financial Advisors LLC raised its stake in shares of Healthpeak Properties by 4.5% in the 4th quarter. United Capital Financial Advisors LLC now owns 63,953 shares of the real estate investment trust's stock valued at $1,296,000 after purchasing an additional 2,769 shares during the period. Finally, Bridgewater Associates LP bought a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $443,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages recently issued reports on DOC. Wedbush reissued an "outperform" rating and issued a $24.00 target price on shares of Healthpeak Properties in a research report on Friday, April 11th. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective on the stock in a report on Wednesday, January 15th. Scotiabank reduced their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Robert W. Baird lowered their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 11th. Finally, StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $23.83.
Read Our Latest Report on Healthpeak Properties
Healthpeak Properties Price Performance
NYSE:DOC opened at $18.81 on Wednesday. Healthpeak Properties, Inc. has a 12-month low of $17.33 and a 12-month high of $23.26. The firm has a market capitalization of $13.16 billion, a price-to-earnings ratio of 53.74, a P/E/G ratio of 2.17 and a beta of 1.02. The stock's 50 day moving average price is $19.63 and its two-hundred day moving average price is $20.63. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.
Healthpeak Properties Announces Dividend
The firm also recently declared a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.1017 per share. This represents a yield of 6.5%. The ex-dividend date is Thursday, April 17th. Healthpeak Properties's dividend payout ratio is 348.57%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.